# PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

> **NCT00943423** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University College, London** · enrollment: 602 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **RADIATION:** Involved Field Radiotherapy
- **OTHER:** No further treatment

## Key facts

- **NCT ID:** NCT00943423
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2003-07
- **Primary completion:** 2014-07
- **Final completion:** 2028-12
- **Target enrollment:** 602 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943423, "PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00943423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*